9-[(1S,2R)-2-FLUORO-1-METHYLPROPYL]-2-METHOXY-6-(N-O-GLUCURONIDE-PIPERAZINE)-PURINE-HYDROCHLORIDE
Compound with spectra: 1 NMR
![9-[(1S,2R)-2-FLUORO-1-METHYLPROPYL]-2-METHOXY-6-(N-O-GLUCURONIDE-PIPERAZINE)-PURINE-HYDROCHLORIDE](/api/compound/KWhC92QWINR.png?ph=true&h=300&w=458 "9-[(1S,2R)-2-FLUORO-1-METHYLPROPYL]-2-METHOXY-6-(N-O-GLUCURONIDE-PIPERAZINE)-PURINE-HYDROCHLORIDE")
| SpectraBase Compound ID | KWhC92QWINR |
|---|---|
| InChI | InChI=1S/C20H29FN6O8.ClH/c1-9(21)10(2)27-8-22-11-16(23-20(33-3)24-17(11)27)25-4-6-26(7-5-25)35-19-14(30)12(28)13(29)15(34-19)18(31)32;/h8-10,12-15,19,28-30H,4-7H2,1-3H3,(H,31,32);1H/t9-,10+,12-,13-,14+,15-,19-;/m1./s1 |
| InChIKey | SINMUGATSQWLDV-FNTPVJBRSA-N |
| Mol Weight | 536.95 g/mol |
| Molecular Formula | C20H30ClFN6O8 |
| Exact Mass | 536.179768 g/mol |
| Parent InChIKey | UKABMRVDIXGSEK-LQKLJOALSA-N |
| Enantiomer InChIKey | SINMUGATSQWLDV-PMAYBKBZSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
7-O-METHYLHESPERETIN-3'-O-(METHYL-BETA-D-GLUCOPYRANOSYLURONATE)
RAC-N(6),N(6)-DIBENZOYL-3'-([(TERT.-BUTYL)-DIPHENYLSILYLOXY]-METHYL)-2',3',5'-TRIDEOXY-5'-(METHOXYCARBONYL)-1'-A-CARBAADENOSINE;METHYL-T-2-([(TER
Methyl c-4-[6'-(dibenzoylamino)-9' H-purin-9'-yl]-t-2-{[(t-butyl)diphenylsilyloxy]methyl})cyclopentane-1-acetate
(1.alpha.,2.beta.,3.beta.,5.beta.)-(.+-.)-N-[3-[6-(dimethylamino)-9H-purin-9-yl]-2-hydroxy-5-[[(4-methoxyphenyl)diphenylmethoxy]methyl]cyclopentyl]acetamide
2,2'-{[2-amino-9-(beta-o-ribofuranosyl)-9H-purin-6-yl]imino]diethanol, monohydrate
Baicalin hydrate
(trans)-zeatin - 9.beta.-D-ribosyl - permethylated derivative
APIGENIN_7-O-BETA-D-(4''-CAFFEOYL)GLUCURONIDE
EDGEWORKOSIDE-C
THELEPHORIC_ACID
| Title | Journal or Book | Year |
|---|---|---|
| IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT | Drug Metabolism and Disposition | 2004 |